PIMREG and chronic kidney disease: A similar suggestion was previously made in a model of chronic renal disease using ApoE−/− CatS-deficient or ApoE−/− mice treated with specific CatS inhibitors, where these mice showed a significantly reduced vascular calcification associated with fewer aortic elastin breaks17,45.